Lysergamides: Difference between revisions
>Dextromethorphan Grammatics |
>Unity Add stub panel. Adjust 'See also' links. Add literature section. |
||
Line 1: | Line 1: | ||
{{headerpanel|{{stub}}}} | |||
[[File:Substituted_lysergamide.svg|thumb|right|250px|Substitutive structure of a ''lysergamide'']] | [[File:Substituted_lysergamide.svg|thumb|right|250px|Substitutive structure of a ''lysergamide'']] | ||
Line 55: | Line 56: | ||
==See also== | ==See also== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
*[[Tryptamine]] | |||
*[[LSD]] | *[[LSD]] | ||
*[[LSA]] | *[[LSA]] | ||
*[[ | *[[AL-LAD]] | ||
*[[ | *[[ETH-LAD]] | ||
==External links== | ==External links== | ||
*[https://en.wikipedia.org/wiki/Lysergamide Lysergamide (Wikipedia)] | *[https://en.wikipedia.org/wiki/Lysergamide Lysergamide (Wikipedia)] | ||
==Literature== | |||
* Pfaff, R. C., Huang, X., Marona-Lewicka, D., Oberlender, R., & Nichols, D. E. (1994). Lysergamides revisited. NIDA Research Monograph, 146, 52-73. https://doi.org/10.1.1.669.2474 | |||
==References== | ==References== | ||
{{references}} | {{references}} |